Dillapiole

Dillapiole

SCHEMBL310992

C=CCc1cc2c(c(OC)c1OC)OCO2

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.71
CYP3A4 P08684 4/20 0.63
ALOX15 P16050 1/20 0.63
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.42
GSK3B P49841 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ATR Q13535 1/20 0.41
TARBP2 Q15633 1/20 0.40
OPRK1 P41145 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24242264 0.91 POLB (0.64) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14552379 0.88 POLB (0.72) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14553815 0.87 POLB (0.57) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14552418 0.86 POLB (0.62) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14552310 0.85 POLB (0.57) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14552325 0.84 POLB (0.59) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14552411 0.84 POLB (0.59) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14552303 0.84 POLB (0.63) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL14552377 0.84 POLB (0.63) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL2424490 0.83 POLB (1.00) POLBCYP3A4ALOX15ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 621 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026107510-A1 HOT-MELT ADHESIVE COMPOSITION AND METHOD OF APPLICATION BIOBOND ADHESIVES, INC. (US) 2026-05-21 WO claimed
US-20260130395-A1 Water Dispersible Botanical Compositions AQUILA BLACK LTD (AU) 2026-05-14 US claimed
EP-4651713-A1 PLANT TREATMENT COMPOSITIONS COMPRISING CHITOSAN-COATED EMULSIONS Universität Münster (DE) 2025-11-26 EP claimed
US-12109187-B2 Antimicrobial compositions and related methods WEST LIBERTY UNIVERSITY (US) 2024-10-08 US claimed
WO-2024153800-A1 PLANT TREATMENT COMPOSITIONS COMPRISING CHITOSAN-COATED EMULSIONS UNIVERSITÄT MÜNSTER (DE) 2024-07-25 WO claimed
WO-2024133655-A1 PEST CONTROL COMPOSITION Reckitt & Colman (Overseas) Hygiene Home Limited (GB) 2024-06-27 WO claimed
US-20240199710-A1 BIOACTIVE POLYPEPTIDES AND METHODS RELATED THERETO LINCOLN UNIVERSITY (NZ) 2024-06-20 US claimed
US-20240008483-A1 COMPOSITION FOR MOLD REMEDIATION MOLD GUARD INC. (CA) 2024-01-11 US claimed
EP-4244364-A1 COMPOSITION FOR MOLD REMEDIATION Mold Guard Inc. (CA) 2023-09-20 EP claimed
EP-4229639-A1 METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE GBS Global Biopharma, Inc. (CA) 2023-08-23 EP claimed
CN-102643174-A Method for preparing dillapiole NANJING ZELANG MEDICAL TECH CO 2012-08-22 CN claimed
WO-2011117424-A1 VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE COMPRISING A COMBINATION OF (-) -CARVONE, GERANIOL AND A FURTHER ESSENTIAL OIL COMPONENT CESA ALLIANCE S.A. (LU) 2011-09-29 WO claimed
CN-102018284-A Natural fragrance functional cigarette with lung nourishing, cough relieving, phlegm eliminating and asthma relieving functions SI GAO 2011-04-20 CN claimed
CN-101830886-A Method for preparing dillapiole by extracting from wild perilla leaves SUZHOU PAITENG BIOPHARMACEUTICAL TECHNOLOGY CO LTD 2010-09-15 CN claimed
EP-2173164-A1 PESTICIDAL EAR TAG Y-Tex Corporation (UA) 2010-04-14 EP claimed
US-20090081119-A1 INHIBITING DNA POLYMERASE BETA TO ENHANCE EFFICACY OF ANTICANCER AGENTS UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-03-26 US claimed
WO-2009005513-A1 PESTICIDAL EAR TAG Y-TEX CORPORATION (US) 2009-01-08 WO claimed
WO-2007001684-A9 INHIBITING DNA POLYMERASE BETA TO ENHANCE EFFICACY OF ANTICANCER AGENTS UNIV PITTSBURGH (US) 2007-04-19 WO claimed
US-20070073089-A1 Process for the Isomerisation of Alkenyl Alkoxybenzenes SYMRISE GMBH & CO. KG (DE) 2007-03-29 US claimed
WO-2007001684-A2 INHIBITING DNA POLYMERASE BETA TO ENHANCE EFFICACY OF ANTICANCER AGENTS UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-01-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130395-A1 Water Dispersible Botanical Compositions TTPA, PNLIP, SRMS POLB 2282/4885CYP3A4 2833/4885ALOX15 1182/4885
US-12109187-B2 Antimicrobial compositions and related methods VCL, MGLL, LIPA POLB 3580/4885CYP3A4 733/4885ALOX15 177/4885
US-20070073089-A1 Process for the Isomerisation of Alkenyl Alkoxybenzenes ADH1C, ADH1A, AKR7A2 POLB 65/4885CYP3A4 40/4885ALOX15 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.